Search the Newsreel

Earnings call transcript: Ampco-Pittsburgh posts Q2 2026 profit as stock rises

Ampco-Pittsburgh Corp. reported a return to profit in Q2 2026, with earnings of $0.07 per share and revenue of $102.9 million, as restructuring efforts improved margins and demand strengthened. The company's stock rose 5.2% in premarket trading. Management anticipates a significantly stronger second half …

BALRAMCHIN: Higher sugar prices and PLA project progress drive stable growth amid tight inventory

Campbell's Co (CPB) Earnings Forecast: Future EPS & Revenue Growth Estimates

Goldfish Are Going Gluten-Free

Campbell's will launch its first certified gluten-free Goldfish crackers nationwide in November, made with a gluten-free flour blend and real cheese. The new product responds to years of consumer requests and aims to boost the company's struggling snacks division. A 5-ounce bag will be …

The Top 5 Analyst Questions From Amplitude’s Q2 Earnings Call

Sampo Group’s results for January–June 2026

Sampo plc Sampo plc, half-year financial report, 12 August 2026 at 8:30 am EEST Sampo Group's results for January–June 2026 Q2/2026 Like-for-like top-line growth accelerated to 5 per cent, driven by continued solid development in Private Nordic as well as improved momentum in Private …

Amprius (AMPX) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Wednesday, Aug. 5, 2026, at 8:30 a.m. ET CALL PARTICIPANTS Chief Executive Officer - Tom StepienChief Financial Officer - Ricardo Rodriguez TAKEAWAYS Revenue -- $34.0 million in the second quarter, representing 19% growth compared to the first quarter …

Ampco Pittsburgh (AP) Stock Rallies As Margin Repair Sparks Profit Return

Ampco-Pittsburgh: Q2 Earnings Snapshot

Ampco-Pittsburgh Corp. (AP) reported a second-quarter net income of $1.5 million, or 7 cents per share, a significant improvement from a loss in the prior year. The steel manufacturer achieved revenues of $102.9 million for the period. The company's stock has seen substantial growth, …

Amphastar Pharmaceuticals (NASDAQ:AMPH) CFO William Peters Sells 8,180 Shares

Amphastar Pharmaceuticals' CFO, William Peters, sold 8,180 shares of the company's stock for a total of $183,886.40, reducing his holdings by 4.52%. This transaction occurred under a pre-arranged Rule 10b5-1 trading plan. The company recently reported strong quarterly earnings, beating analyst estimates for both …

Ampco-Pittsburgh Corporation Q2 2026 Earnings Call Summary

Ampco-Pittsburgh Corporation Q2 2026 Earnings Call Summary - Moby Strategic Performance Drivers Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. Tap here. Management identified …

Amplify Energy Corp. (AMPY) stock price, news, quote and history

Amphastar (AMPH) CFO exercises options and sells 8,180 shares in 10b5-1 trade

Amphastar Pharmaceuticals' CFO, William J. Peters, exercised 5,053 employee stock options at $19.79 per share and subsequently sold 8,180 shares of common stock at $22.48 per share on August 7, 2026. This sale was conducted under a Rule 10b5-1 trading plan adopted on March …

Balrampur Chini Shares Fall 6% After Q1 Profit Dips 14.5%

Sampann Utpadan India accepts resignation of Independent Director Shiv Kumar

AMPH (AMPH) schedules Rule 144 stock sale tied to RSU vesting

Amphastar Pharmaceuticals (AMPH) has filed a Rule 144 notice for the proposed sale of 7,973 shares of common stock, valued at $161,931.63, through UBS Financial Services Inc. The sale is scheduled for August 11, 2026, and is linked to multiple Restricted Stock Unit (RSU) …

D.A. Davidson reiterates Neutral rating on LiveRamp stock

D.A. Davidson reiterated a Neutral rating and $38.50 price target for LiveRamp Holdings Inc. after the company reported a slight revenue beat and better-than-expected profitability. LiveRamp is set to be acquired by Publicis by the end of 2026, which led to the company not …

Ampco-Pittsburgh (NYSE:AP) Releases Earnings Results, Misses Estimates By $0.01 EPS

Amprius at Canaccord Genuity conference: growth built on silicon edge

Amprius Technologies (AMPX) recently presented at Canaccord Genuity's 46th Annual Growth Conference, highlighting its rapid growth driven by silicon anode batteries that offer double the energy density of traditional graphite cells. The company raised its 2024 revenue outlook to at least $140 million and …

Balrampur Chini Mills Limited Reports Earnings Results for the First Quarter Ended June 30, 2026

Amplia Therapeutics Ltd (ASX:ATX) Share Price Update: Trading Snapshot for 11 August 2026

Ampco-Pittsburgh Q2 Results: Net income turns profitable

Ampco-Pittsburgh (NYSE: AP) reported a return to profitability in Q2 2026 with a net income of $1.5 million, reversing a prior-year loss, largely due to improved operating performance and the absence of U.K. exit costs. Despite a decrease in net sales to $102.9 million, …

Campbell’s Co. formulates gluten-free Goldfish

The Campbell's Co. is launching a gluten-free version of its popular Goldfish crackers, addressing consumer demand for inclusive snack options. Available in the classic cheddar flavor, Goldfish Gluten Free crackers will hit retailers nationwide in November. This move ensures that more families can enjoy …

Ampco-Pittsburgh Q2 Earnings Call Highlights

Key Points Interested in Ampco-Pittsburgh Corporation? Here are five stocks we like better. Ampco-Pittsburgh returned to profitability in Q2 2026, reporting $1.5 million in net income versus a $7.3 million loss a year earlier. Adjusted EBITDA rose 22% to $9.8 million, with margins expanding …

Benchmark cuts Amplify Energy stock price target on wider oil differential

Benchmark has lowered its price target for Amplify Energy Corp. (NYSE:AMPY) to $9.00 from $11.00, while maintaining a Buy rating. This adjustment is primarily due to a wider oil differential caused by fewer California refineries. Despite the lowered target, the company has positive developments, …

Form 8K Ampco-Pittsburgh Corp For: 11 August By Investing.com

The article reports on the filing of a Form 8K by Ampco-Pittsburgh Corp on August 11. It mentions the company's stock symbol AP and its price performance, showing a 13.03% increase. The content is brief and primarily serves as an announcement for the SEC …

Balrampur Chini Mills profit falls 10% in Q1FY27; appoints Vartika Shukla

Ampco-Pittsburgh shares rise 7% as profitability returns and backlog grows

Ampco-Pittsburgh (NYSE:AP) shares surged after the company reported a return to profitability in Q2, with earnings of $0.07 per share. Despite a 9% decline in net sales, adjusted EBITDA increased by 22% due to improved margins. The company also saw a 50% jump in …

CAMP4 Therapeutics Corporation (NASDAQ:CAMP) Given Average Recommendation of "Moderate Buy" by Analysts

Analysts have given CAMP4 Therapeutics Corporation (NASDAQ:CAMP) an average recommendation of "Moderate Buy," with seven analysts recommending a buy and two a sell. The average 12-month price target is $8.36, significantly higher than the current share price of $4.22. Recent actions include an upgrade …

Balrampur Chini Mills Q1 net profit slides 15% despite 6% rise in revenue

Ampco-Pittsburgh stock climbs 7% on return to profit, rising backlog

Amphenol (APH) After Its Dividend Update And The Case For A Full Valuation

Ampco-Pittsburgh (NYSE: AP) posts Q2 2026 profit and stronger cash flow

Ampco‑Pittsburgh 2Q 2026: Revenue $102.92M, EPS $0.07— 10-Q Summary

Ampco-Pittsburgh Corp (AP) reported its second-quarter 2026 results, showing revenue of $102.92 million and diluted EPS of $0.07. While revenue saw a 9% year-over-year decline, the company achieved a positive net income of $2.15 million, a significant improvement from the prior-year's loss. Business highlights …

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Receives Average Recommendation of "Reduce" from Analysts

Amphastar Pharmaceuticals (NASDAQ:AMPH) has received an average "Reduce" recommendation from eight brokerages, with two analysts rating it a "sell" and six a "hold." Despite this cautious sentiment and an average 12-month price target of $22.00, the company recently surpassed earnings expectations, reporting $0.91 EPS …

BALRAMCHIN: Q1 FY27 saw revenue growth, capital infusion, and a new independent director appointment